Biotech | Chadds Fords, PA.
MOBILion Closes $35M Series B Financing Round for Biomarker Discovery Instrumentation
MOBILion Systems, Inc., a provider of high-resolution instrumentation for biomarker discovery, diagnostics and therapeutic development, closed an oversubscribed $35 million Series B funding round led by aMoon. Funds will be used to build the commercial team supporting the launch of the company's first product based on the patented ion mobility separations technology, called Structures for Lossless Ion Manipulation (SLIM). [Full story]